PL448149A1 - Peptyd o działaniu osteogennym oraz jego zastosowanie - Google Patents

Peptyd o działaniu osteogennym oraz jego zastosowanie

Info

Publication number
PL448149A1
PL448149A1 PL448149A PL44814924A PL448149A1 PL 448149 A1 PL448149 A1 PL 448149A1 PL 448149 A PL448149 A PL 448149A PL 44814924 A PL44814924 A PL 44814924A PL 448149 A1 PL448149 A1 PL 448149A1
Authority
PL
Poland
Prior art keywords
lys
peptide
arg
application
phe
Prior art date
Application number
PL448149A
Other languages
English (en)
Inventor
Michał PIKUŁA
Agata Tymińska
Aneta Skoniecka
Małgorzata Zawrzykraj
Jacek ZIELIŃSKI
Sylwia RODZIEWICZ-MOTOWIDŁO
Natalia Karska
Agnieszka Kubiś
Piotr Skowron
Original Assignee
Uniwersytet Gdański
Gdański Uniwersytet Medyczny
Politechnika Gdańska
Innovabion Spółka Z Ograniczoną Odpowiedzialnością
Nex.D Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Gdański, Gdański Uniwersytet Medyczny, Politechnika Gdańska, Innovabion Spółka Z Ograniczoną Odpowiedzialnością, Nex.D Spółka Z Ograniczoną Odpowiedzialnością filed Critical Uniwersytet Gdański
Priority to PL448149A priority Critical patent/PL448149A1/pl
Publication of PL448149A1 publication Critical patent/PL448149A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Przedmiotem zgłoszenia jest peptyd oznaczony jako UG27 0 sekwencji aminokwasowej Phe-Phe-Gly-Val-Asn-Pro-Lys-Tyr-Lys-Gln-Lys-Arg-Arg - (FFGVNPKYKQKRR) stanowiący środek o działaniu stymulującym osteogenezę komórek mezenchymanych pozyskiwanych z tkanki tłuszczowej. Zgłoszenie obejmuje również zastosowanie medyczne peptydu UG27 jako leku, który może pobudzać proces osteogenezy w komórkach stromalnych u ludzi w celu leczenia ubytków kostnych.
PL448149A 2024-03-29 2024-03-29 Peptyd o działaniu osteogennym oraz jego zastosowanie PL448149A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL448149A PL448149A1 (pl) 2024-03-29 2024-03-29 Peptyd o działaniu osteogennym oraz jego zastosowanie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL448149A PL448149A1 (pl) 2024-03-29 2024-03-29 Peptyd o działaniu osteogennym oraz jego zastosowanie

Publications (1)

Publication Number Publication Date
PL448149A1 true PL448149A1 (pl) 2025-10-06

Family

ID=97229885

Family Applications (1)

Application Number Title Priority Date Filing Date
PL448149A PL448149A1 (pl) 2024-03-29 2024-03-29 Peptyd o działaniu osteogennym oraz jego zastosowanie

Country Status (1)

Country Link
PL (1) PL448149A1 (pl)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103880928A (zh) * 2014-03-28 2014-06-25 甘少磊 一种诱导成骨短肽及其制备方法和用途
EP3505529A1 (en) * 2016-08-26 2019-07-03 Sewon Biotechnology Inc. Peptide for promoting osteoanagenesis or osteogenesis and use of same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103880928A (zh) * 2014-03-28 2014-06-25 甘少磊 一种诱导成骨短肽及其制备方法和用途
EP3505529A1 (en) * 2016-08-26 2019-07-03 Sewon Biotechnology Inc. Peptide for promoting osteoanagenesis or osteogenesis and use of same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEN, Y., LIU, X., LIU, R., GONG, Y., WANG, M., HUANG, Q., FENG, Q., YU, B.: "Theranostics 2017, 7, 1072-1087.", ZERO-ORDER CONTROLLED RELEASE OF BMP2-DERIVED PEPTIDE P24 FROM THE CHITOSAN SCAFFOLD BY CHEMICAL GRAFTING MODIFICATION TECHNIQUE FOR PROMOTION OF OSTEOGENESIS IN VITRO AND ENHANCEMENT OF BONE REPAIR IN VIVO. *
LEE, D., PARK, K.S., YOON, G.J., LEE, H.J., LEE, J.Y., PARK, Y.S., PARK, J.C., LEE, G., CHUNG, C.P., PARK, Y.J.: "J Biomed Mater Res A 2019, 107, 2392-2402.", IDENTIFICATION OF CELL-PENETRATING OSTEOGENIC PEPTIDE FROM COPINE-7 PROTEIN AND ITS DELIVERY SYSTEM FOR ENHANCED BONE FORMATION. *

Similar Documents

Publication Publication Date Title
Jevotovsky et al. Osteoarthritis and stem cell therapy in humans: a systematic review
Muramatsu et al. Recalcitrant posttraumatic nonunion of the humerus: 23 patients reconstructed with vascularized bone graft: 23 patients reconstructed with vascularized bone graft
Maan et al. Cell recruitment by amnion chorion grafts promotes neovascularization
RU2319483C2 (ru) Способ лечения и предупреждения потери костной ткани
DE69813908D1 (de) Verwendung von kreatinsubstanzen zur behandlung von knochen- und knorpelzellen und geweben
DK1599575T3 (da) Fremgangsmåder til anvendelse af adipøst vævs-afledte celler i behandlingen af kardiovaskulære tilstande
DE69634748D1 (de) Verwendung von fibroblasten-wachstumsfaktor analogen zur stimulation des knochenwachstums
EP2305276A3 (en) Processed lipoaspirate cells for use in therapy
ATE269102T1 (de) Verwendung von fibroblastwachstumsfaktoren zur stimulierung des knochenwachstums
WO2004073616A3 (en) Elastin digest compositions and methods utilizing same
DE60106002D1 (de) Behandlung von hematopoietischen zellen mit cxcr4 agonisten
Zhai et al. Human autologous mesenchymal stem cells with extracorporeal shock wave therapy for nonunion of long bones
ATE377026T1 (de) Behandlung von fettleibigkeit
PL448149A1 (pl) Peptyd o działaniu osteogennym oraz jego zastosowanie
EA200001124A1 (ru) Способ генной терапии
ATE165008T1 (de) Methode zur behandlung intestinaler krankheiten
Klewin-Steinböck et al. Potential usefulness of enamel matrix derivative in skin and mucosal injury treatment
AR003974A1 (es) Una nueva proteina mp52 arg humana, un proceso para la produccion y aislacion de la misma y composiciones farmaceuticas que la contienen
PL448148A1 (pl) Peptydy o działaniu chondrogenicznym jako stymulatory chondrogenezy oraz ich zastosowanie
NO20054912L (no) Behandling av aspergillus infeksjoner med tymosin alfa 1
TWI851183B (zh) 植入式壓電骨材
Pavlenko et al. THE ROLE OF PLASMA ENRICHED WITH PLATELETS AND GROWTH FACTORS IN MODERN MEDICAL PRACTICE
TW201614066A (en) Composition for treatment of joint disease and method thereof
ES8502613A1 (es) Procedimiento para la obtencion de un producto para el tratamiento de arrugas.
CA3242504A1 (en) Treatment of therapy-induced enteropathy